| __timestamp | Rhythm Pharmaceuticals, Inc. | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5280000 | 18516000 |
| Thursday, January 1, 2015 | 7148000 | 34140000 |
| Friday, January 1, 2016 | 19594000 | 51872000 |
| Sunday, January 1, 2017 | 22894000 | 71772000 |
| Monday, January 1, 2018 | 50337000 | 97501000 |
| Tuesday, January 1, 2019 | 109450000 | 118590000 |
| Wednesday, January 1, 2020 | 90450000 | 169802000 |
| Friday, January 1, 2021 | 104128000 | 192507000 |
| Saturday, January 1, 2022 | 108630000 | 199563000 |
| Sunday, January 1, 2023 | 134951000 | 253598000 |
Igniting the spark of knowledge
Over the past decade, the landscape of research and development (R&D) in the pharmaceutical industry has seen significant shifts. Rhythm Pharmaceuticals and Xencor, two prominent players, have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Xencor consistently outpaced Rhythm Pharmaceuticals, with R&D expenses growing by approximately 1,270% compared to Rhythm's 2,455% increase. Notably, in 2023, Xencor's R&D spending reached a peak, nearly doubling its 2019 figures, while Rhythm Pharmaceuticals also saw a substantial rise, marking a 25% increase from the previous year. This trend underscores the growing emphasis on innovation and development in the biotech sector, as both companies strive to enhance their competitive edge. As the industry evolves, these investments are crucial for driving breakthroughs and maintaining market leadership.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for GSK plc and Rhythm Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xencor, Inc.
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and Rhythm Pharmaceuticals, Inc.
Blueprint Medicines Corporation or Xencor, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Xencor, Inc.
Rhythm Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Comparing Innovation Spending: Vericel Corporation and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Soleno Therapeutics, Inc. and Xencor, Inc.
R&D Spending Showdown: Evotec SE vs Xencor, Inc.